Home › Products › Oncology › Docecad 20mg Injection
Docecad 20mg Injection
Salt Composition: DOCETAXEL
- Manufacturer: CADILA PHARMACEUTICALS LTD
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 20MG
- Prescription Required
- Storage: Keep Docecad Injection out of sight and reach of children. Store in a refrigerator (2 - 8°C). Do not freeze.
₹900.00₹2686.05
Inclusive of all taxes
Product Introduction
Docecad 20mg Injection is an anti-cancer medication indicated for patients with breast cancer, non-small cell lung cancer, prostate cancer, stomach cancer, and head and neck cancer. It contains Docetaxel, a taxoid that works by slowing or stopping cancer cell growth. The medicine is administered as an intravenous infusion by a qualified healthcare professional. Your doctor will determine the dose and duration based on your condition, body weight, and treatment response. It may be used as monotherapy or in combination with other chemotherapy medicines. Follow your doctor's instructions carefully. Do not miss doses or discontinue treatment without medical advice, even if benefits are not immediately apparent—it may take several weeks or months for effects to become evident.
Uses
Docecad 20mg uses are to treat: Non-small cell lung cancer Breast cancer Stomach or gastric cancer Prostate cancer Head and neck cancer
How it works
Docecad 20mg Injection works by disrupting the structure called microtubules inside cancer cells. These microtubules help cancer cells divide and grow. By preventing this, the medicine slows down and stops the multiplication of cancer cells, eventually helping to shrink the tumor.
Side Effects
Like most chemotherapy medicines, Docecad 20mg Injection can cause side effects. Most are manageable, but some may need medical attention. Common side effects : Fatigue or weakness Hair loss Nausea, vomiting Loss of appetite Constipation or diarrhea Swelling (edema) in hands or feet Mouth ulcers or sore throat Nail changes (discoloration or brittleness) Muscle or joint pain Altered sense of taste Low blood cell count (increased risk of infections) Serious side effects : Unexplained bruising or bleeding High fever or persistent sore throat Severe allergic reaction (rash, itching, swelling) Severe abdominal pain or diarrhea Shortness of breath Your doctor may monitor your blood counts and liver function regularly during treatment.
Expert Tips
To reduce side effects like fluid retention, your doctor may give corticosteroids before and after treatment. Stay hydrated and eat small, frequent meals to manage nausea. Report any persistent fever, unusual bleeding, or severe fatigue to your doctor immediately. Women of childbearing potential should use reliable birth control during and for 6 months after treatment. Men receiving Docecad are also advised to use contraception and avoid fathering a child for at least 6 months after the last dose.
References
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1707 - 1709.
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 866.
- Seacross Pharma (Europe) Ltd, Electronic medicines compendium (EMC), [ Revised on May 2022] [ Accessed on 26 Nov 2021], https://www.medicines.org.uk/emc/files/pil.7206.pdf
- Sanofi-aventis US LLC, US Food and Drug Administration, [ Revised on May 2020] [ Accessed on 26 Nov 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020449s084lbl.pdf
- Angela M Davies et al; Docetaxel in non-small cell lung cancer: a review; Expert Opinion on Pharmacotherapy; Published on April 2003; Accessed on 26/09/2022; https://pubmed.ncbi.nlm.nih.gov/12667118/
- Katherine A Lyseng-Williamson, Caroline Fenton; Docetaxel: a review of its use in metastatic breast cancer; Drugs; Published on 2005; Accessed on 26/09/2022; https://pubmed.ncbi.nlm.nih.gov/16296875/
Safety Advice
Pregnancy: unsafe It is unsafe to use during pregnancy as it may cause harmful effects on the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and six months after the final dose.
Lungs: unsafe Inform your physician if you have any lung problems before the treatment with Docecad 20mg Injection.
Breastfeeding: unsafe It is not recommended to breastfeed during the treatment with Docecad 20mg 0.5ml inj and for one week after the last dose.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.